Recent Updates
Recently added Catalysts

Radical prostatectomy

Phase 3

Prostate Cancer | Unknown | Oncology |National Healthcare Corp.|Last Updated: Feb 24, 2020

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

RandomizedNO_TREATMENT_CONTROLLEDDMCBiomarker
Total Trials1
Total Enrollment731

FDA Designations

No designations recorded

Clinical trial landscape

Radical prostatectomy · 1 trial · 1 indication

Phase 3 1
NCT00007644Prostate Cancer Intervention Versus Observation Trial (PIVOT)Prostate Cancer
COMPLETED731 Analytics
PHASE3COMPLETED
Prostate Cancer Intervention Versus Observation Trial (PIVOT)
Prostate CancerUnlock trial analytics

Study Endpoints

Primary Endpoints

All Cause Mortality
From date of randomization until date of death from any cause, assessed until end of study, up to 16 years

Number of deaths from any cause.

Unlock Study Endpoints

Study Design & Arms

AllocationRANDOMIZED
MaskingNONE
ModelPARALLEL
PurposeTREATMENT

Treatment Arms

ArmTypeDescription
Radical ProstatectomyOTHERSurgical removal of the prostate
Watchful WaitingNO_INTERVENTIONClosely watching, waiting and treating symptoms if and when cancer progresses

Interventions

NameTypeDescription
Radical prostatectomyPROCEDURESurgical removal of the prostate
Unlock Study Design Details

Eligibility Criteria

Age RangeN/A to 75 Years
SexMALE
Healthy VolunteersNo
Study Sites31

Inclusion Criteria: * Patients with clinically localized CAP * Diagnosis of Prostate Cancer within previous 6 months * Age 75 years or younger Exclusion Criteria: PSA \> 50 ng/ml Bone scan consistent with metastatic disease Other evidence that cancer of the prostate is not clinically localized Di...

Countries:United States
Unlock Eligibility Criteria

Competitive Landscape -Prostate Cancer 254 trials

Frequently asked questions about Radical prostatectomy

What is Radical prostatectomy used for in Prostate Cancer?

Radical prostatectomy is a surgical procedure used for the treatment of prostate cancer. It involves the complete removal of the prostate gland and surrounding tissues to eliminate cancerous cells. This procedure is typically considered for patients with localized prostate cancer, aiming to achieve curative resection and prevent cancer progression.

Who is developing Radical prostatectomy?

Radical prostatectomy is being developed by National Healthcare Corp., a company listed on the stock exchange under the ticker symbol NHC. The company is conducting clinical trials to evaluate the efficacy and safety of this surgical intervention in patients with prostate cancer.

What phase is Radical prostatectomy in?

Radical prostatectomy is currently in Phase 3 clinical development. It is an investigational surgical procedure, meaning it is still being studied in clinical trials to determine its effectiveness and safety for the treatment of prostate cancer. It has not yet been approved for general use.

What clinical trials is Radical prostatectomy in?

Radical prostatectomy is being evaluated in the clinical trial NCT00007644, titled 'Prostate Cancer Intervention Versus Observation Trial (PIVOT)'. This Phase 3 trial has been completed and enrolled 731 male participants with prostate cancer in the United States. The trial compared the surgical procedure to a no-treatment control.

Is Radical prostatectomy the same as PIVOT?

No, Radical prostatectomy is not the same as PIVOT. PIVOT is the name of the clinical trial (NCT00007644) that evaluates Radical prostatectomy. The trial is a Phase 3 study that compares the surgical procedure to observation without treatment in patients with prostate cancer.